Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms, Hormone-Dependent 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Paclitaxel 6Carboplatin 6Radiotherapy 5Chemotherapy, Adjuvant 5Cyclophosphamide 4Trastuzumab 3Tamoxifen 3Letrozole 3Doxorubicin 3Brachytherapy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3pertuzumab 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Magnetic Resonance Spectroscopy 2Epirubicin 2talimogene laherparepvec 1sargramostim 1palbociclib 1ferric carboxymaltose 1atezolizumab 1atamestane 1aldesleukin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1VPS Coriolus versicolor extract 1Toremifene 1Thiotepa 1Therapeutics 1Reverse Transcriptase Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Ductal, Breast × Estrogen Receptor Modulators × Clear all
NCT00044291 2015-07-31

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Intarcia Therapeutics

Phase 3 Completed
865 enrolled
Breast

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡